InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0001055726-22-000017 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-09 2022-03-08 INO KIES PETER CFO M - OptEx — +21.5K 162.2K +15% —
D 2022-03-09 2022-03-08 INO KIES PETER CFO F - Tax $3.26 -11.3K 151.0K -7% -$36.8K
D 2022-03-09 2022-03-08 INO KIES PETER CFO M - OptEx $0.00 -21.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-08 M A 21,466 — 162,244 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2 Common Common Stock 2022-03-08 F D 11,287 $3.26 150,957 D — —
3 Derivative Restricted Stock Unit 2022-03-08 M D 21,466 $0.00 0 D — · — to — 21,466 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares vested on March 8, 2020; 21,467 shares vested on March 8, 2021; 21,466 shares vested on March 8, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.